Education, Research, Patient Care
Poliovirus therapy for recurrent glioblastoma has three-year survival rate of 21 percent.
Read MoreDuke's Preston Robert Tisch Brain Tumor Center is now enrolling qualified pediatric patients in our new PVSRIPO clinical trial for children. This exciting trial is designed for pediatric patients with recurring brain tumors. A similar trial has shown promising results for our adult patients. Eric Thompson, MD, will serve as principal investigator. Visit clinicaltrials.gov to learn more.
Angels Among Us is the largest and most successful fundraising effort of its kind in all of North Carolina. Funds raised support brain cancer research at The Preston Robert Tisch Brain Tumor Center. Help make a difference. The below buttons help you connect with Angels Among Us and the many ways to get involved.
Donate To Angels Among Us
Form a Team
Volunteer
Learn More